HeartBeam (NASDAQ: BEAT) announced a strategic collaboration with the Icahn School of Medicine at Mount Sinai in New ...
Stocktwits on MSN
HeartBeam and Mount Sinai announce strategic AI collaboration to bring clinical-grade heart monitoring into the home
Accelerates development of personalized cardiac AI on the HeartBeam platform for wellness and clinical applications, including assessing heart attack risk ・Combines Mount Sinai’s world-class AI and ...
HeartBeam, Inc. BEAT shares are trading higher Tuesday after the company announced a strategic partnership with Mount Sinai to accelerate the joint development and validation of next-generation AI-ECG ...
10h
The "Galapagos" Effect in Ad Tech: Why Japan Is the Ultimate Stress Test for Your Global Strategy
TikTok has emerged as a massive vulnerability in the Japanese ecosystem. Recent updated data reveals it is the undisputed leading source of invalid traffic by volume, exposing campaigns to over 63.2 ...
Ad fraud is the most prolific form of cybercrime. So why haven't you heard of it? TOKYO, JP / ACCESS Newswire / March 10, 2026 / Digital advertising looks measurable, and that is a problem.Dashboards ...
What’s the first thing you think of when you hear about ai security threats and vulnerabilities? If you’re like most people, your mind probably jumps to Large Language Model (LLM) ...
Codex Genetics, a leading precision diagnostics company headquartered in Hong Kong, today announces a strategic collaboration ...
Founded in 2009 by Anand Sivaraman, Remidio builds hardware and AI tools that enable early detection of eye diseases and, increasingly, systemic health risks through retinal analysis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results